DocSym
β
Searchsearch
Search
(N13.7) Vesicoureteral-reflux-associated uropathy
More details coming soon
5 611 627 in individuals diagnosis vesicoureteral-reflux-associated uropathy confirmed
32 552 deaths with diagnosis vesicoureteral-reflux-associated uropathy
1% mortality rate associated with the disease vesicoureteral-reflux-associated uropathy
Diagnosis vesicoureteral-reflux-associated uropathy is diagnosed Women are 1.35% more likely than Men
2 767 959
Men receive the diagnosis vesicoureteral-reflux-associated uropathy
16 886 (0.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
2 843 668
Women receive the diagnosis vesicoureteral-reflux-associated uropathy
15 666 (0.6 %)Died from this diagnosis.
Risk Group for the Disease vesicoureteral-reflux-associated uropathy - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features vesicoureteral-reflux-associated uropathy
Absence or low individual and public risk
Vesicoureteral-reflux-associated uropathy - what does this mean
Vesicoureteral-reflux-associated uropathy is a condition in which urine flows back up from the bladder to the kidneys, resulting in inflammation of the renal pelvis and ureter. this can lead to scarring of the kidneys and the development of kidney disease.
What happens during the disease - vesicoureteral-reflux-associated uropathy
Vesicoureteral-reflux-associated uropathy is caused by a failure of the ureteral valves to close properly, allowing urine to flow backwards into the kidneys. this backward flow of urine can cause inflammation and damage to the renal tissue, leading to scarring and eventual kidney failure if left untreated.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Urine analysis
- Imaging tests such as X-ray, Ultrasound, CT scan, or MRI
- Voiding cystourethrogram (VCUG)
- Renal function tests
- Renal biopsy
- Urodynamic testing
Treatment and Medical Assistance
Main goal of the treatment: To reduce the risk of infection and damage to the kidneys
- Antibiotic prophylaxis
- Regular follow-up visits to the doctor
- Regular urine tests
- Dietary modifications
- Fluid intake management
- Surgery to correct the reflux
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Vesicoureteral-reflux-associated uropathy - Prevention
The best way to prevent vesicoureteral-reflux-associated uropathy is to identify and treat the underlying cause of the condition. this includes lifestyle modifications such as avoiding dehydration, maintaining a healthy weight, avoiding bladder irritants, and avoiding constipation. additionally, regular monitoring of urine output and urine cultures should be done to detect any infection and early intervention should be done to prevent any further damage.